A detailed history of Smartleaf Asset Management LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 184 shares of ITCI stock, worth $15,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares
184
Previous 101 82.18%
Holding current value
$15,766
Previous $7.17 Million 88.16%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$67.99 - $80.84 $5,643 - $6,709
83 Added 82.18%
184 $13.5 Million
Q2 2024

Aug 13, 2024

BUY
$64.76 - $79.84 $6,540 - $8,063
101 New
101 $7.17 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.09B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.